Ligand Binding Assay Market
Ligand Binding Assay Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Ligand Binding Assay Market Size and Growth
The Ligand Binding Assay market is experiencing significant growth, driven by rising demand in drug development and diagnostics. The global market size is projected to reach approximately $3 billion by 2028, with advancements in technology and increasing research activities further propelling market expansion across pharmaceuticals and biotechnology sectors.
Companies Covered
(Covid 19 Impact Covered)
◍ Sygnature Discovery
◍ Shanghai Medicilon Inc
◍ Intertek Group plc
◍ PerkinElmer Inc
◍ Charles River
◍ Alliance Pharma
◍ Eurofins Discovery
◍ Creative Biogene
◍ IBR Inc
◍ LGC Limited
◍ Accelero Bioanalytics GmbH
◍ Gifford Bioscience Limited
◍ GE Healthcare
◍ Antigen Discovery Inc
The Ligand Binding Assay Market features companies like Sygnature Discovery, Shanghai Medicilon, and PerkinElmer, providing solutions for drug development and biomarker discovery. They enhance market growth through innovative assays and robust analytics. Sales revenues include:
- PerkinElmer: $3 billion
- Charles River: $3.2 billion
- Eurofins: $5.6 billion.
Request Sample Report
Market Segmentation
By Application
Biomedical Research
Drug Discovery
Others
Request Sample Report
By Product
Radioactive
Non-radioactive
Market Growth
Request Sample Report
$ X Billion USD
